Paul Averback, CEO, Director, Ten Percent Owner at Nymox Pharmaceutical, holds 23.33M shares in Nymox Pharmaceutical (Ticker: NYMXF). Most recently, Paul Averback Sold $100,000 shares of Nymox Pharmaceutical on Nov 06, 2018 for an estimated value of 175.00K.
What is the percentage of profitable transactions made by Paul Averback?
The percentage of profitable transactions made by Paul Averback is 100%.
What is the average return per transaction made by Paul Averback?
The average return per transaction made by Paul Averback is 9.50%.
What stocks does Paul Averback hold?
Paul Averback holds: NYMXF stocks.
What was Paul Averback’s latest transaction?
Paul Averback latest transaction was an Informative Sell of $175.00K.
What was Paul Averback's most profitable transaction?
Paul Averback’s most profitable transaction was an Informative Sell of NYMXF stock on November 6, 2018. The return on the trade was 9.50%.
What is Paul Averback's role in Nymox Pharmaceutical?
Paul Averback's role in Nymox Pharmaceutical is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.